Arbitration has become a common tool for settling pay disputes in two very different American industries: professional baseball and health care. In both cases, a neutral third party steps in to decide a financial disagreement. The outcomes, however, have been radically different, highlighting the limits of applying one system to another.
In Major League Baseball, arbitration is widely seen as a success. Players and teams unable to agree on a salary for the upcoming season present their cases to a panel. The panel then chooses one side’s proposed figure, with no middle ground. This structure encourages both sides to make reasonable offers, as an extreme number is more likely to lose.
The system works because both parties operate within a shared market with clear performance statistics. A player’s value can be measured against his peers, and teams have a strong incentive to keep costs under control. Over time, arbitration has helped maintain a balance between player earning power and team budgets.
Health care arbitration operates on a similar premise but with far different results. When doctors and insurers disagree on payment for medical services, arbitration is often used to resolve the dispute. However, the lack of standardized pricing in health care means there is no clear baseline for what a service should cost.
Unlike baseball, where player performance is easy to quantify, medical pricing is complex and often opaque. Insurers negotiate rates with hospitals and doctors in private, leading to wide variations in costs. Arbitrators in these cases lack the transparent data that makes baseball arbitration effective.
Additionally, the incentives in health care are misaligned. In baseball, teams and players share a common goal of putting a winning team on the field. In health care, insurers and providers have fundamentally different objectives: one focuses on minimizing costs, while the other seeks to maximize revenue. This creates a zero-sum game where arbitration cannot easily reach a fair outcome.
Another key difference is the role of the consumer. Baseball fans are not directly affected by a player’s salary arbitration. In health care, the results of payment disputes can influence premiums, out-of-pocket costs, and access to care for millions of patients. The stakes are far higher, yet the process offers little clarity.
Experts argue that health care arbitration often ends up reinforcing existing market power instead of correcting it. Providers with strong negotiating leverage may still win favorable rulings, while smaller practices struggle. This undermines the intended purpose of arbitration as a fair and neutral tool.
The contrast between these two industries offers a clear lesson. Arbitration is not a one-size-fits-all solution. Its success depends on a well-defined market, reliable data, and aligned incentives. In health care, those conditions are largely missing, making arbitration a poor substitute for broader pricing reform.
Policymakers looking to control health care costs would do well to study this divergence. The answer may lie not in tweaking arbitration rules but in addressing the fundamental lack of transparency in medical pricing. Until then, the same method that works for baseball will continue to produce inconsistent and often frustrating results in health care.
